Species-dependent blood-brain barrier disruption of lipopolysaccharide: Amelioration by colistin in vitro and in vivo

Search results

• Finished

  Targeting Superbugs: discovery and development of new broad-spectrum lipopeptide

  Li, J. (Primary Chief Investigator (PCI)), Dudley, M. N. (Chief Investigator (CI)), Griffith, D. (Chief Investigator (CI)), Hecker, S. (Chief Investigator (CI)), Lomovskaya, O. (Chief Investigator (CI)), Nation, R. (Chief Investigator (CI)), Roberts, K. (Chief Investigator (CI)), Thompson, P. (Chief Investigator (CI)) & Velkov, T. (Chief Investigator (CI))

  NIH - National Institutes of Health (United States of America)

  1/06/12 → 31/05/17

  Project: Research

• Optimizing dosing of colistin for infections resistant to all other antibiotics.

  Nation, R. (Primary Chief Investigator (PCI)) & Li, J. (Chief Investigator (CI))

  NIH - National Institutes of Health (United States of America)

  15/09/08 → 31/08/12

  Project: Research

• Targeting MD hetero-resistant Gram-negatives: PK/PD for rational combinations.

  Nation, R. (Primary Chief Investigator (PCI)), Li, J. (Chief Investigator (CI)), Forrest, A. (Partner Investigator (PI)), Paterson, D. L. (Partner Investigator (PI)) & Tsuji, B. T. (Partner Investigator (PI))

  NIH - National Institutes of Health (United States of America)

  15/07/08 → 30/06/12

  Project: Research